Article Details

Ex-Axovant COO Marion McCourt lands at Regeneron; GT Biopharma elevates Shawn Cross to ...

Retrieved on: 2018-02-15 22:03:45

Tags for this article:

Click the tags to see associated articles and topics

Ex-Axovant COO Marion McCourt lands at Regeneron; GT Biopharma elevates Shawn Cross to .... View article details on hiswai:

Excerpt

<div>Following Genocea's $55 million public offering led by <b>New Enterprise</b> <b>Associates</b>, NEA partner Ali Behbahani will join the board of the cancer vaccine developer $GNCA. → Aimmune Therapeutics $AIMT, the biotech being watched for its peanut allergy drug, has recruited two more allergy experts to his ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up